Occlusion Catheter Isolates Local Treatment Chamber

The Occlusion Perfusion Catheter (OPC) has the ability to create a localized treatment chamber for the delivery of various therapeutic agents, treating a variety of disease states by placing drugs circumferentially into the vasculature. The treatment chamber is created by inflating the distal and proximal inflation lumens, isolating the section of vasculature. The therapeutic agent is then pumped into the inflow port and out again via the outflow port. An additional inflation lumen in the center of the chamber section can be inflated to increase pressure in the treatment chamber.

The device has sensors to measure pressure applied inside the treatment chamber, which can be adjusted by using the inflow and outflow ports for chamber evacuation, filling, and flushing. It affords clinicians substantial procedural control and the ability to select the treatment agent and volume, while significantly limiting systemic release of the treatment agent. The OPC is a product of Advanced Catheter Therapies (ACT; Chattanooga, TN, USA), and has been approved by the US Food and Drug Administration (FDA).

“We strongly feel the OPC, which has strong intellectual property and patent protection, is positioned to be the next generation of therapeutic agent delivery devices,” said Paul J. Fitzpatrick, CEO of ACT.

Related Links:
Advanced Catheter Therapies